Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHL.L Regulatory News (RHL)

  • There is currently no data for RHL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Capital Reduction

21 Aug 2017 07:00

RNS Number : 4757O
Redhall Group PLC
21 August 2017
 

For immediate release 21 August 2017

 

Redhall Group plc

("Redhall" or the "Company") 

 

Proposed Capital Reduction

 

Notice of General Meeting

 

Introduction

 

The Board of Redhall (the "Board") announces that the Company will later today post a circular (the "Circular") to shareholders of Redhall ("Shareholders") detailing a proposed reduction in the capital of the Company (the "Capital Reduction") and convening a general meeting of the Company (the "General Meeting"), the purpose of which is to enable Shareholders to approve the Capital Reduction.

 

The Company does not currently have distributable reserves and is therefore prohibited from making distributions to Shareholders, including the payment of dividends. The Board believes it is an appropriate time to create distributable reserves, which would allow the Company to pay dividends should it be considered desirable to do so in the future, and is therefore proposing the Capital Reduction to effect this.

 

A copy of the Circular will shortly be available on the Company's website at www.redhallgroup.co.uk.

 

Below are extracts from the Circular which should be read in conjunction with the full text. Defined terms used in this announcement have the meaning ascribed to them in the Circular.

 

The Capital Reduction

 

At 30 September 2016, the Company had a profit and loss account deficit of £32,973,000. At the same date, the balance standing to the credit of the Company's share premium account and merger reserve amounted to £28,326,000 and £12,679,000 respectively. The Share Premium Account was further increased in July 2017 upon the issue of new Ordinary Shares in connection with a previously announced placing and debt conversion and as at 31 July 2017 stood at £40,934,339. As at 31 July 2017, the profit and loss account deficit had also increased. However, the Capital Reduction, if approved and made effective, will be sufficient to eliminate this deficit entirely and create distributable reserves.

 

The Capital Reduction is proposed to be effected by cancelling the balances standing to the credit of the Share Premium Account and (having first created and issued Capital Reduction Shares to capitalise the merger reserve) the merger reserve. Cancelling the balance of the Share Premium Account and the Capital Reduction Shares will, subject to the discharge of any undertakings required by the Court, be sufficient to eliminate the deficit on the profit and loss account. As a result, any positive distributable reserves generated by the Company after the date on which the Capital Reduction takes effect would be available for the Board to use for the purposes of paying dividends (should circumstances in the future make it desirable to do so).

 

It is therefore proposed that:

 

a. the amount standing to the credit of the Company's merger reserve in the sum of £12,678,593 is capitalised by way of a bonus issue of newly created Capital Reduction Shares;

b. the newly created Capital Reduction Shares are cancelled; and

c. the amount standing to the credit of the Share Premium Account (such amount being, as at 31 July 2017, £40,934,339) is cancelled. 

 

In addition to the approval by Shareholders, the Capital Reduction requires the approval of the Court. Accordingly, following the General Meeting, an application will be made to the Court in order to confirm and approve the Capital Reduction.

 

There will be no change in the number of Ordinary Shares in issue (or their nominal value) following the implementation of the Capital Reduction. The Capital Reduction itself will not involve any distribution or repayment of capital or share premium by the Company and will not reduce the underlying net assets of the Company. The distributable reserves arising on the Capital Reduction will, subject to the discharge of any undertakings required by the Court support the Company's ability to pay dividends, should circumstances in the future make it desirable to do so.

 

Background to, and reasons for, the Capital Reduction

 

Following the successful implementation of its strategic turnaround programme, the Group has been transformed from a site-based contractor and manufacturer into a high integrity manufacturing business with significant growth prospects. As at June 2017, the Group's order book had progressed to £32 million with a pipeline of outstanding bids and other identified opportunities. The Group is currently accelerating its growth into key markets, in particular investing in its capability to serve customers in three core (and growing) nuclear-related sectors: defence, decommissioning and new build. Booth Industries and Jordan Manufacturing are the Group's key businesses serving these sectors.

 

The Group's growth plans anticipate increased volumes and margins driven by improved trading terms with the Group's supply chain, improved competitiveness and by investment in the people, plant and equipment, processes and technology required to meet customer requirements in complex and hazardous environments.

In July 2017, the Company raised £9.53 million through a placing of new Ordinary Shares and converted £3.75 million of debt into equity. The Company has also refinanced its borrowings with HSBC Bank plc and LOIM for a further four years. These actions have significantly improved the Company's balance sheet and, in the Board's opinion, provided the flexibility to implement the Group's growth plans.

 

In light of the Group's growth prospects, the Board believes that it might be considered desirable in the future to commence paying dividends to Shareholders. However, the Company currently has negative distributable reserves and is, therefore, prohibited under the Act from making distributions to its Shareholders, including the payment of dividends.

 

The Board, therefore, believes it is an appropriate time to undertake the Capital Reduction and create distributable reserves which would enable the payment of dividends in the future. In addition, the Board believes the Capital Reduction will have the effect of further strengthening the balance sheet and improving the Group's access to capital.

 

The General Meeting

 

The General Meeting will take place at 10.00 a.m. on 5 September 2017 at the offices of Squire Patton Boggs (UK) LLP at 7 Devonshire Square, London, EC2M 4YH. At the General Meeting, a resolution (the "Resolution") will be proposed to Shareholders to seek their approval of the Capital Reduction.

 

The Resolution will be passed if 75 per cent. or more of the votes cast (in person or by proxy) at the General meeting are in favour of it.

 

Shareholders should note that unless the Resolution is approved at the General Meeting (and the Court subsequently confirms the Capital Reduction) the Capital Reduction will not take place.

 

Directors' recommendation

 

The Directors consider that the Capital Reduction will be beneficial for the Company and its Shareholders as a whole. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the Resolution to be proposed at the General Meeting, as they intend to do in respect of their aggregate shareholdings, of 3,027,455 Ordinary Shares representing approximately 0.9% of the Ordinary Shares in issue.

 

Expected timetable

 

 

2017

Posting of the Circular and Form of Proxy

21 August 2017

Latest time and date for receipt of Forms of Proxy for the General Meeting

10.00 a.m. on 3 September 2017

Time and date of the General Meeting

10.00 a.m. on 5 September 2017

Initial directions hearing of Court

12 September 2017

Court Hearing to conform the Capital Reduction

20 September 2017

Effective date of Capital Reduction

21 September 2017

 

Each of the times and dates above refer to London time. The expected dates for the confirmation of the Capital Reduction by the Court and the Capital Reduction becoming effective are based on provisional dates that have been obtained for the required Court hearings of the Company's application. These provisional hearing dates are subject to change and dependent on the Court's timetable. Any such change will be notified to Shareholders by an announcement on a Regulatory Information Service.

 

Redhall's Chief Executive Officer, Phil Brierley, commented: 

 

"At the time of our interim results in June we highlighted the momentum in Redhall's recovery and our confidence in being able to deliver profitable growth. At the appropriate time, once this profitability is established, we would like to return Redhall to the dividend list, both to reward existing shareholders and to increase the marketability of Redhall shares. This proposed capital reduction is an essential procedural step to enable dividend payments to be made."

 

 

For further information please contact:

 

Redhall Group plc

Phil Brierley, Chief Executive

Chris Kelly, Group Finance Director

 

Buchanan, PR

Mark Court, Sophie Cowles

 

GCA Altium, NOMAD

Tim Richardson, Simon Lord

Tel: +44 (0) 1924 385 386

 

 

 

Tel: +44 (0) 20 7466 5000

 

Tel: +44 (0) 845 505 4343

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEMEESFWSEIA
Date   Source Headline
10th Jun 20195:30 pmRNSRedhall Group
10th Jun 20193:39 pmRNSAppointment of Administrators
28th May 201910:20 amRNSIntention to appoint administrators
24th May 20197:30 amRNSSuspension - Redhall Group plc
24th May 20197:30 amRNSTrading update and Suspension of trading on AIM
1st May 20197:00 amRNSTrading Update
24th Apr 20199:59 amRNSNotification of Major Holdings
6th Mar 20191:17 pmRNSResult of AGM
6th Mar 20197:00 amRNSAGM Statement
12th Feb 20197:00 amRNSPosting of Annual Report
11th Feb 20195:27 pmRNSNotification of Major Holdings
6th Feb 20194:57 pmRNSNotification of Major Holdings
31st Jan 20197:00 amRNSPreliminary Results
25th Jan 20197:00 amRNSShort Term Funding Agreement
6th Dec 20187:00 amRNSNotification of Full Year Results: Date Change
16th Nov 20182:30 pmRNSNotification of Full Year Results
25th Oct 20187:00 amRNSBoard Changes
1st Oct 20181:33 pmRNSNotification of Major Holdings
26th Sep 20187:00 amRNSFull Year Trading Update
13th Jun 20187:00 amRNSInterim Results
15th May 20187:00 amRNSNotice of Interim Results
26th Apr 20182:11 pmRNSNotification of Major Holdings
23rd Apr 20187:00 amRNSDirectorate Changes
15th Mar 20187:00 amRNSContract Awards and Trading Update
1st Feb 201812:46 pmRNSResult of AGM
1st Feb 20187:00 amRNSAGM Statement
20th Dec 20177:00 amRNSPosting of Annual Report
19th Dec 20177:00 amRNSJordan Manufacturing Wins Nuclear Contract
6th Dec 20177:00 amRNSPreliminary Results
10th Nov 20173:40 pmRNSNotification of Preliminary Results
4th Oct 20177:00 amRNSFull Year Trading Update
2nd Oct 20173:51 pmRNSGrant of Options
21st Sep 20177:00 amRNSCompletion of Capital Reduction
20th Sep 20175:50 pmRNSNotification of Major Holdings
5th Sep 201710:24 amRNSCapital Reduction: Result of General Meeting
21st Aug 20177:00 amRNSProposed Capital Reduction
11th Aug 201710:10 amRNSDirector / PDMR Shareholdings
31st Jul 201710:30 amRNSTotal Voting Rights
12th Jul 201711:37 amRNSNotification of Major Interest in Shares
12th Jul 201711:13 amRNSNotification of Major Interest in Shares
5th Jul 20178:51 amRNSDirector Shareholdings
30th Jun 201711:29 amRNSResult of General Meeting
30th Jun 20178:55 amRNSTR1: Notification of Major Interest in Shares
27th Jun 20177:00 amRNSAppointment of Chief Operating Officer
14th Jun 201711:14 amRNSResult of Placing
14th Jun 20177:00 amRNSProposed Placing and Debt Conversion
14th Jun 20177:00 amRNSInterim Results
10th May 201710:10 amRNSTR1: Notification of Major Interest in Shares
5th Apr 20174:06 pmRNSHolding(s) in Company
1st Feb 20171:40 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.